The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.10
Bid: 22.00
Ask: 22.45
Change: 0.90 (4.25%)
Spread: 0.45 (2.045%)
Open: 22.00
High: 22.45
Low: 21.45
Prev. Close: 22.10
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

26 Jun 2012 07:00

RNS Number : 1056G
Allocate Software PLC
26 June 2012
 



ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

 

Full Year Trading Update

 

Allocate Software (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, announces an update on trading for its financial year ended 31 May 2012. The Company's final results will be announced in the week commencing 30 July 2012.

 

Highlights

 

§ Strong financial performance in the year with results expected to be in line with market expectations.

 

§ Healthcare had another successful year securing new customers across the NHS, in the UK private healthcare sector and overseas.

 

§ Completed two acquisitions in the financial year: Zircadian in the UK and RosterOn in Australia. Both performed in line with expectations and the cross-sell of different products into the customer base is beginning to yield encouraging results.

 

§ Defence had a record year, with major contract wins worldwide including the multi million pound agreement with the Australian Defence Forces.

 

Healthcare

 

Because of the drive in the NHS for efficiency and cost savings, market appetite for the Allocate application suite with its proven ROI remained strong, with new customers, new products, licence renewals and extensions. HealthRoster, our e-rostering product, retained its strong competitive position and was selected in the majority of all competitive tenders in the UK during the fiscal year.

 

The release of v10, the fully web-based version of HealthRoster with multi-language capability, positions this product well for further internationalisation. Our Swedish business, Time Care, has again performed well and met expectations as it has now done every year since acquisition. HealthRoster will be available in Swedish as the first internationalisation of HealthRoster in the coming months.

 

Leveraging acquisitions - the integration of HealthRoster and the Zircadian products with the rest of the Allocate suite of products provides customers with an end to end solution from planning to scheduling of the medical workforce. In addition, the integration of HealthRoster and the RosterOn product has created a bespoke leading employment awards interpretation engine for the Australian market. The broadening of our product range is creating significant cross-sell opportunities, in line with our strategy.

 

Defence

 

The Defence business achieved substantial growth and continued diversifying into other geographic regions, generating significant business from overseas. Highlights include:

 

§ Securing a multi-million pound licence contract with the Australian Defence Department extending the use of Defence Suite across the Army, Navy and civilians under military control.

§ Substantial additional Consultancy Services contract extension wins with the Royal Australian Navy, as part of their New Generation Navy programme.

§ Two new Consultancy Services contract wins in NATO within their Force Operations Group, and Special Forces HQ.

§ Extension of the UK Army Support contract to 2014

 

Maritime

 

§ Secured a new licence agreement with McDermott Inc, a major US offshore engineering company, the third in this sector

§ Completed a major Maritime Suite implementation to support SubSea7's global Offshore Oil Services operations

 

 

Ian Bowles, Chief Executive Officer of Allocate commented: "Despite the global economic environment and the macro economics of UK government spending we have executed well in our industry sectors and I am delighted with the performance of Allocate this year, particularly in the second half.

 

"2012 was our sixth consecutive year of record revenue. This consistency of execution, I believe, demonstrates a balance across our business, both in terms of vertical markets and geographical focus, which speaks well to our plans for significant growth over the next three to five years. I am very pleased with this year's performance and look forward to Allocate's continued success in the next financial year".

 

 

Enquiries:

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Michael Meade / Simon Willis/ Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James / John Bick

 

Tel: +44 (0) 20 7193 7463

M: +44 (0) 7525 324431

 

About Allocate Software plc

Allocate Software plc is the leading workforce optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

 

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVRNRUOANUAR
Date   Source Headline
7th May 20247:10 amRNSConference Attendance – CG Global Metals & Mining
7th May 20247:00 amRNSDog-Leg Delivers Further High-grade Intersections
2nd May 20247:00 amRNSApproval to List on the Ghana Stock Exchange
24th Apr 20247:00 amRNSQuarterly Activities and Cash Flow Report
18th Apr 20247:00 amRNSExploration-focused Investor Webinar
16th Apr 20247:00 amRNSInvestor Presentation - Paydirt Battery Minerals
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFurther Broad and High-Grade Drill Intersections
15th Mar 20247:00 amRNSHalf-year Financial Report
27th Feb 20247:00 amRNSConference Attendance
15th Feb 20247:00 amRNSDirector/PDMR Dealings
5th Feb 20247:00 amRNSMultiple Broad and High-Grade Drill Intersections
2nd Feb 20247:00 amRNSConference Attendance – Mining Indaba
1st Feb 20248:20 amRNSInvestor Presentation - Investor Webinar
31st Jan 20247:00 amRNSQuarterly Activities and Cash Flow Report
29th Jan 20247:00 amRNSInvestor Webinar
25th Jan 20247:00 amRNSUpdate on Competitive Offtake Partnering Process
24th Jan 20247:00 amRNSCompletion of US$5m MIIF Subscription
23rd Jan 20247:00 amRNSTR-1 Notification of Major Holdings
2nd Jan 20247:00 amRNSCorporate Update - Director / PDMR Shareholding
29th Dec 20237:00 amRNSCorporate Update - Director / PDMR Shareholding
28th Dec 20237:00 amRNSGrant of PDMR Performance Rights
22nd Dec 20237:00 amRNSDirector / PDMR Dealings & Shareholding Update
21st Dec 20237:00 amRNSCorporate Update - Director / PDMR Dealings
20th Dec 20237:00 amRNSBoard Changes
15th Dec 20237:00 amRNSSuccessful Completion of A$8million Equity Placing
14th Dec 20234:45 pmRNSA$7 million Equity Placing
12th Dec 20237:00 amRNSMaiden Feldspar Mineral Resource Estimate
30th Nov 202311:57 amRNSAmended Constitution
30th Nov 202311:50 amRNSResult of Annual General Meeting
30th Nov 20237:02 amRNSAGM Statement
28th Nov 20237:00 amRNS106m Continuous Pegmatite Interval Reported
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.